Updated on 05/26/2022

Biosimilars: Interchangeable Products May Increase Patient Access

Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients.

Additional FDA resources you may find helpful:

Article published by CMS on May 26, 2022
CLICK HERE to read original post